For example, miR-148a has been documented to function as a tumor suppressor in pancreatic cancer, gastric cancer, and breast cancer through targeting ErbB3 [30], STAT3 [31], and CCK-BR [32], respectively. Here, ERBB3 is linked to pancreatic neoplasm.